Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
Poly(I:C) (HMW) VacciGrade™ Lipid Microparticles Show Similar Efficacy With Lipid Nanoparticles in Delive... 2022 Pharm Res. Ji A. et al. DOI: 10.1007/s11095-022-03445-1
IFA IFNGR/STAT1 signaling in recipient hematopoietic antigen presenting cells sup... 2022 J Clin Invest. Lu C. et al. DOI: 10.1172/JCI125986
EndoFit™ OVA protein IFNGR/STAT1 signaling in recipient hematopoietic antigen presenting cells sup... 2022 J Clin Invest. Lu C. et al. DOI: 10.1172/JCI125986
Blasticidin Novel trehalose-based excipients for stabilizing nebulized anti-SARS-CoV-2 an... 2022 Int J Pharm. Noverraz F. et al. DOI: 10.1016/j.ijpharm.2022.122463
Normocin® - Antimicrobial Reagent Novel trehalose-based excipients for stabilizing nebulized anti-SARS-CoV-2 an... 2022 Int J Pharm. Noverraz F. et al. DOI: 10.1016/j.ijpharm.2022.122463
SARS-CoV-2 Spike expressing HEK293 cells Novel trehalose-based excipients for stabilizing nebulized anti-SARS-CoV-2 an... 2022 Int J Pharm. Noverraz F. et al. DOI: 10.1016/j.ijpharm.2022.122463
G418 (Geneticin) Rationally designed antifungal protein chimeras reveal new insights into stru... 2022 Int J Biol Macromol. Giner-Llorca M. et al. DOI: 10.1016/j.ijbiomac.2022.11.280
Pam3CSK4 Pim1 promotes IFN-β production by interacting with IRF3. 2022 Exp Mol Med. Ko R. et al. DOI: 10.1038/s12276-022-00893-y
Zeocin® Biallelic TLR4 deficiency in humans. 2022 J Allergy Clin Immunol. Capitani M. et al. DOI: 10.1016/j.jaci.2022.08.030
Human MD2 and CD14 Reporter HEK293 Cells (NF-κB) Biallelic TLR4 deficiency in humans. 2022 J Allergy Clin Immunol. Capitani M. et al. DOI: 10.1016/j.jaci.2022.08.030
HEK-Blue™ Detection Biallelic TLR4 deficiency in humans. 2022 J Allergy Clin Immunol. Capitani M. et al. DOI: 10.1016/j.jaci.2022.08.030
Hygromycin B Gold Biallelic TLR4 deficiency in humans. 2022 J Allergy Clin Immunol. Capitani M. et al. DOI: 10.1016/j.jaci.2022.08.030
CL075 (3M002) Comparison of the immunomodulatory potential of platinum-based anti-cancer dr... 2022 Cancer Chemother Pharmacol. Jenei V. et al. DOI: 10.1007/s00280-022-04497-1
QUANTI-Luc™: Luciferase Detection Reagent Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitme... 2022 J Immunother Cancer Cyr M.G. et al. DOI: 10.1136/jitc-2022-004850
Jurkat Reporter Cells (NFAT) Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitme... 2022 J Immunother Cancer Cyr M.G. et al. DOI: 10.1136/jitc-2022-004850
LumiKine™ Xpress mIFN-β 2.0 Tumor-targeted delivery of a STING agonist improves cancer immunotherapy. 2022 PNAS Wu Y.T. et al. DOI: 10.1073/pnas.2214278119
RAW-Lucia™ ISG Cells Tumor-targeted delivery of a STING agonist improves cancer immunotherapy. 2022 PNAS Wu Y.T. et al. DOI: 10.1073/pnas.2214278119
THP1-Lucia™ ISG Cells Tumor-targeted delivery of a STING agonist improves cancer immunotherapy. 2022 PNAS Wu Y.T. et al. DOI: 10.1073/pnas.2214278119
CR3022-derived Anti-SARS-CoV2 RBD mAbs, human & mouse isotypes Two formulations of coronavirus disease-19 recombinant subunit vaccine candid... 2022 Immun Inflamm Dis. Özcengiz E. et al. DOI: 10.1002/iid3.748
Nucleocapsid (N) Expression Vector Two formulations of coronavirus disease-19 recombinant subunit vaccine candid... 2022 Immun Inflamm Dis. Özcengiz E. et al. DOI: 10.1002/iid3.748

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty